Grant Opportunities from Pfizer Inc.
Explore all the grants from the leading funding organizations of the world in a single place
Optimizing Early Biomarker Testing to Guide Clinical Decision-Making in Colorectal Cancer Across Latin America
Pfizer Inc. offers grants for medical education initiatives to improve biomarker testing and clinical decision-making in colorectal cancer across Latin America.
Published At
Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOS
Pfizer Inc. offers research grants for interventional studies exploring novel brentuximab vedotin combinations in AITL and PTCL-NOS for US-based investigators.
Published At
Pfizer Independent Medical Education: Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical Cancer
Pfizer Inc. offers educational grants for projects focused on the evolving treatment landscape and management of recurrent or metastatic cervical cancer in the US.
Published At
Pfizer Quality Improvement Request for Proposals: Implementing Shared Decision Making in Hemophilia Patient Care
Pfizer Inc. offers grants up to $30,000 for US-based organizations to implement Shared Decision Making tools and patient-reported outcomes in hemophilia patient care.
Published At
Advancing Adult Immunization Strategies: A Focus on the Impact of Respiratory Syncytial Virus (RSV) and Cardiorespiratory Outcomes
Pfizer Inc. offers grants up to $200,000 for medical education initiatives focused on the impact of RSV infection and cardiorespiratory outcomes in high-risk adults.
Published At
Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer (NSCLC)
Pfizer Inc. offers grants up to $250,000 for educational activities to improve healthcare professional understanding of clinical data and management in ALK+ mNSCLC.
Published At
AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction Management
Pfizer Inc. offers research grants for AI-enabled solutions to improve COVID-19 antiviral treatment access and manage drug-drug interactions for eligible patients.
Published At
Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence Approach
Pfizer Inc. offers research grants up to $100,000 for US-based investigators to evaluate the impact of early vs. delayed ritlecitinib treatment in Alopecia Areata patients.
Published At
Biochemical and Molecular Characterization of Marstacimab and TFPI Pathways
Pfizer Inc. offers research grants for basic science studies on TFPI, anti-TFPI Monoclonal Antibodies, and marstacimab to advance molecular and cellular understanding.
Published At
Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders
Pfizer Inc. offers research grants for preclinical studies on TFPI modulation in non-hemophilic bleeding disorders, supporting investigators with up to $50,000 USD.
Published At